Fibrin glue and clinical impact on haemophilia care

Abstract

Fibrin glues, a kind of biological sealant, have been used for enhancement of local haemostasis, tissue sealing and wound healing for haemophilia and similar disorders. Commercial viral-inactivated fibrin glue products are available in Europe and have recently been approved in the USA. Using fibrin glue, hospitalization, medical cost, viral transmission risk and factor supplementation will be reduced. In the near future, the role of fibrin glues will be increased in the haemophilia field.